Literature DB >> 16501946

Variable costs of ICU patients: a multicenter prospective study.

Carlotta Rossi1, Bruno Simini, Luca Brazzi, Giancarlo Rossi, Danilo Radrizzani, Gaetano Iapichino, Guido Bertolini.   

Abstract

OBJECTIVE: To analyze the costs of treating critically ill patients. DESIGN AND
SETTING: Multicenter, observational, prospective, cohort, bottom-up study on variable costs in 51 ICUs. PATIENTS AND PARTICIPANTS: A total of 1,034 patients aged over 14 years who either spent less than 48 h in the ICU or had multiple trauma, major abdominal surgery, ischemic stroke, chronic obstructive pulmonary disease, cardiac failure, isolated head injury, acute lung injury/adult respiratory distress syndrome (ALI/ARDS), nontraumatic intracranial hemorrhage or coronary surgery.
INTERVENTIONS: Data recorded for each patient: length of ICU stay, and cost in euros of all diagnostic and therapeutic procedures, drugs and equipment used, and consultations by physicians from other units. To express cost-efficiency we calculated for each diagnostic group the cost per surviving patient (expenditure for all patients/number of surviving patients) and money loss per patient (expenditure for patients who died/total number of patients). MEASUREMENTS AND
RESULTS: Median costs for a multiple trauma patient were euro 4076 and for coronary surgery patient euro 380. The variability is largely due to different lengths of ICU stay. Cost per surviving patient was higher for ALI/ARDS, nontraumatic intracranial hemorrhage, multiple trauma, and emergency abdominal surgery. Money loss per patient was higher for ALI/ARDS and lower for multiple trauma. Planned coronary and major abdominal surgery and short-stay patients were treated most cost-efficiently.
CONCLUSIONS: Cost of treatment in an ICU varies widely for different types of patients. Strategies are needed to contain the major determinants of high costs and low cost-efficiency.

Entities:  

Mesh:

Year:  2006        PMID: 16501946     DOI: 10.1007/s00134-006-0080-2

Source DB:  PubMed          Journal:  Intensive Care Med        ISSN: 0342-4642            Impact factor:   17.440


  23 in total

Review 1.  How to use the results of an economic evaluation.

Authors:  D K Heyland; A Gafni; P Kernerman; S Keenan; D Chalfin
Journal:  Crit Care Med       Date:  1999-06       Impact factor: 7.598

2.  Can health care costs be reduced by limiting intensive care at the end of life?

Authors:  John M Luce; Gordon D Rubenfeld
Journal:  Am J Respir Crit Care Med       Date:  2002-03-15       Impact factor: 21.405

3.  Top-down costing: problems in determining staff costs in intensive care medicine.

Authors:  Luca Brazzi; Guido Bertolini; Enrico Arrighi; Franco Rossi; Rebecca Facchini; Davide Luciani
Journal:  Intensive Care Med       Date:  2002-09-07       Impact factor: 17.440

4.  Descriptive patient data as an explanation for the variation in average daily costs in intensive care.

Authors:  P Jacobs; D Edbrooke; C Hibbert; K Fassbender; M Corcoran
Journal:  Anaesthesia       Date:  2001-07       Impact factor: 6.955

Review 5.  The pathophysiology and treatment of sepsis.

Authors:  Richard S Hotchkiss; Irene E Karl
Journal:  N Engl J Med       Date:  2003-01-09       Impact factor: 91.245

6.  A new method of accurately identifying costs of individual patients in intensive care: the initial results.

Authors:  D L Edbrooke; V G Stevens; C L Hibbert; A J Mann; A J Wilson
Journal:  Intensive Care Med       Date:  1997-06       Impact factor: 17.440

7.  Evaluation of proposed casemix criteria as a basis for costing patients in the adult general intensive care unit.

Authors:  V G Stevens; C L Hibbert; D L Edbrooke
Journal:  Anaesthesia       Date:  1998-10       Impact factor: 6.955

8.  Dear SIRS, I'm sorry to say that I don't like you...

Authors:  J L Vincent
Journal:  Crit Care Med       Date:  1997-02       Impact factor: 7.598

Review 9.  A review of cost studies of intensive care units: problems with the cost concept.

Authors:  M Gyldmark
Journal:  Crit Care Med       Date:  1995-05       Impact factor: 7.598

10.  A cost-utility analysis of intensive therapy. II: Quality of life in survivors.

Authors:  S Ridley; M Biggam; P Stone
Journal:  Anaesthesia       Date:  1994-03       Impact factor: 6.955

View more
  23 in total

1.  Invasive devices: no need? No use!

Authors:  Stijn I Blot; Renaat Peleman; Koenraad H Vandewoude
Journal:  Intensive Care Med       Date:  2006-12-05       Impact factor: 17.440

Review 2.  Statin therapy for acute respiratory distress syndrome: an individual patient data meta-analysis of randomised clinical trials.

Authors:  Myura Nagendran; Daniel F McAuley; Peter S Kruger; Laurent Papazian; Jonathon D Truwit; John G Laffey; B Taylor Thompson; Mike Clarke; Anthony C Gordon
Journal:  Intensive Care Med       Date:  2016-12-21       Impact factor: 17.440

Review 3.  Economics of ICU organization and management.

Authors:  Hannah Wunsch; Hayley Gershengorn; Damon C Scales
Journal:  Crit Care Clin       Date:  2011-10-22       Impact factor: 3.598

4.  One-year mortality, quality of life and predicted life-time cost-utility in critically ill patients with acute respiratory failure.

Authors:  Rita Linko; Raili Suojaranta-Ylinen; Sari Karlsson; Esko Ruokonen; Tero Varpula; Ville Pettilä
Journal:  Crit Care       Date:  2010-04-12       Impact factor: 9.097

5.  ACCM/PALS haemodynamic support guidelines for paediatric septic shock: an outcomes comparison with and without monitoring central venous oxygen saturation.

Authors:  Cláudio F de Oliveira; Débora S F de Oliveira; Adriana F C Gottschald; Juliana D G Moura; Graziela A Costa; Andréa C Ventura; José Carlos Fernandes; Flávio A C Vaz; Joseph A Carcillo; Emanuel P Rivers; Eduardo J Troster
Journal:  Intensive Care Med       Date:  2008-03-28       Impact factor: 17.440

Review 6.  Cost and health care utilization in ARDS--different from other critical illness?

Authors:  Thomas Bice; Christopher E Cox; Shannon S Carson
Journal:  Semin Respir Crit Care Med       Date:  2013-08-11       Impact factor: 3.119

7.  Cost-Drivers in Acute Treatment of Severe Trauma in Europe: A Systematic Review of Literature.

Authors:  Hans-Christoph Pape; Edmund Neugebauer; Saxon A Ridley; Osvaldo Chiara; Tina G Nielsen; Michael C Christensen
Journal:  Eur J Trauma Emerg Surg       Date:  2008-07-21       Impact factor: 3.693

Review 8.  Tissue-Resident Macrophages in the Control of Infection and Resolution of Inflammation.

Authors:  Xingjiang Mu; Yutian Li; Guo-Chang Fan
Journal:  Shock       Date:  2021-01-01       Impact factor: 3.454

9.  Keratinocyte growth factor in acute lung injury to reduce pulmonary dysfunction--a randomised placebo-controlled trial (KARE): study protocol.

Authors:  Laurence J M Cross; Cecilia M O'Kane; Cliona McDowell; Jospeh J Elborn; Michael A Matthay; Daniel F McAuley
Journal:  Trials       Date:  2013-02-18       Impact factor: 2.279

10.  pRotective vEntilation with veno-venouS lung assisT in respiratory failure: A protocol for a multicentre randomised controlled trial of extracorporeal carbon dioxide removal in patients with acute hypoxaemic respiratory failure.

Authors:  J J McNamee; M A Gillies; N A Barrett; A M Agus; R Beale; A Bentley; A Bodenham; S J Brett; D Brodie; S J Finney; A J Gordon; M Griffiths; D Harrison; C Jackson; C McDowell; C McNally; G D Perkins; W Tunnicliffe; A Vuylsteke; T S Walsh; M P Wise; D Young; D F McAuley
Journal:  J Intensive Care Soc       Date:  2016-12-19
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.